For research use only. Not for therapeutic Use.
RIG-1 modulator 1(Cat No.:I013010), is an anti-viral compound that shows potential for the treatment of viral infections such as influenza virus, HBV (Hepatitis B virus), HCV (Hepatitis C virus), and HIV (Human Immunodeficiency Virus). It is extracted from the patent WO 2015172099 A1. While specific details about its mechanism of action and other characteristics are not available, its designation as a RIG-1 modulator suggests that it may target the RIG-I (Retinoic acid-inducible gene I) pathway, which is involved in innate immune responses against viral infections.
Catalog Number | I013010 |
CAS Number | 1428729-63-8 |
Molecular Formula | C₁₄H₁₇N₅OS₂ |
Purity | ≥95% |
Target | HBVHCVHIVInfluenza Virus |
Solubility | DMSO |
Storage | Store at -20°C |
IUPAC Name | 1-[2-(dimethylamino)ethyl]-3-(7-methyl-[1,3]thiazolo[5,4-e][1,3]benzothiazol-2-yl)urea |
InChI | InChI=1S/C14H17N5OS2/c1-8-16-11-10(21-8)5-4-9-12(11)22-14(17-9)18-13(20)15-6-7-19(2)3/h4-5H,6-7H2,1-3H3,(H2,15,17,18,20) |
InChIKey | HORUPPJGOWQYBQ-UHFFFAOYSA-N |
SMILES | CC1=NC2=C(S1)C=CC3=C2SC(=N3)NC(=O)NCCN(C)C |
Reference | [1]. Shawn P. Iadonato, et al. Anti-viral compounds, pharmaceutical compositions, and methods of use thereof . WO 2015172099 A1. |